| |
| |
|
| Insider
Information: |
Henwood Geraldine |
| Relationship: |
President and CEO, Dir... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
229,001 |
|
|
Indirect Shares
|
50,014 |
|
|
| Direct
Value |
$249,231 |
|
|
|
Indirect Value
|
$55,000 |
|
|
| Total
Shares |
279,015 |
|
|
| Total
Value |
$304,231 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Map Pharmaceuticals Inc |
MAPP |
Director |
2013-02-28 |
0 |
2009-11-18 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director |
2014-01-15 |
0 |
2012-08-24 |
0 |
Premium* |
|
|
Societal CDMO, Inc |
SCTL |
Director |
2021-04-20 |
226,574 |
2021-04-20 |
50,000 |
Premium* |
|
|
Baudax Bio, Inc. |
BXRX |
President and CEO, Dir... |
2022-12-15 |
2,427 |
2022-12-15 |
14 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCTL |
Societal CDMO, Inc |
President and CEOOfficer |
• • – |
2014-03-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEOOfficer |
• • – |
2014-03-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
50,000 |
|
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEO |
• • – |
2017-09-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,100 |
135,600 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEO |
• • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
175,806 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEO |
• • – |
2018-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
180,806 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEO |
• • – |
2019-01-18 |
4/A |
A |
$0.00 |
$0 |
D/D |
40,864 |
215,872 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEO |
• • – |
2019-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
215,809 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEO |
• • – |
2019-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
35,801 |
210,809 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEO |
• • – |
2019-01-18 |
4/A |
OE |
$0.00 |
$0 |
D/D |
5,000 |
220,872 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2019-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
323,958 |
353,868 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEO |
• • – |
2019-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
93,550 |
246,691 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
President and CEO |
• • – |
2020-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
246,746 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2020-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,070 |
372,938 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2021-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
206,467 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
65,435 |
350,307 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2021-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
26,923 |
226,574 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,473 |
49,093 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-12-15 |
4 |
D |
$0.31 |
$5,777 |
D/D |
(18,636) |
336,716 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-12-05 |
4 |
D |
$0.35 |
$3,204 |
D/D |
(9,155) |
355,352 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-09-22 |
4 |
B |
$0.59 |
$4,798 |
D/D |
8,200 |
364,507 |
2.73 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2009-11-18 |
4 |
OE |
$0.64 |
$10,418 |
D/D |
16,250 |
16,250 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2010-10-27 |
4 |
OE |
$0.64 |
$16,229 |
D/D |
9,764 |
3,750 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2010-08-05 |
4 |
OE |
$0.74 |
$8,921 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2012-11-23 |
4 |
OE |
$0.74 |
$13,028 |
D/D |
5,240 |
3,750 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-05-07 |
4 |
B |
$0.83 |
$4,992 |
D/D |
6,000 |
356,307 |
2.73 |
- |
|
57 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
